Disseminated mucormycosis with cerebellum involvement due to Rhizomucor pusillus in a patient with multiple myeloma and secondary myelodysplastic syndrome: A case report
- PMID: 31656543
- PMCID: PMC6812476
- DOI: 10.3892/etm.2019.8065
Disseminated mucormycosis with cerebellum involvement due to Rhizomucor pusillus in a patient with multiple myeloma and secondary myelodysplastic syndrome: A case report
Abstract
Mucormycosis is an angioinvasive fungal infection with a high mortality rate. Patients with hematological malignancies following voriconazole therapy are at high risk from mucormycosis. Here, the present study reports on a 68-year-old man diagnosed with multiple myeloma and secondary myelodysplastic syndrome, who was infected with disseminated mucormycosis with cerebellum involvement confirmed by mycological culture and histopathological examination. For patients with hematological malignancies who are receiving antifungal therapy, an opportunistic infection of mucormycosis should be considered if a 'breakthrough' infection occurs in the predilection sites (such as the sinuses, lungs, skin, brain and gastrointestinal tract). It is difficult to diagnose mucormycosis because of the limited reliable detection methods, and because mucormycosis often presents with an acute onset and progresses rapidly, particularly in immunocompromised patients. Antifungal therapy with amphotericin B or posaconazole should be started as soon as possible considering the empirical diagnosis.
Keywords: Rhizomucor pusillus; autopsy; hematological malignancies; mucormycosis; mycological culture; voriconazole.
Copyright: © Chen et al.
Figures



Similar articles
-
[Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].Rev Iberoam Micol. 2015 Jan-Mar;32(1):46-50. doi: 10.1016/j.riam.2013.03.002. Epub 2013 Apr 11. Rev Iberoam Micol. 2015. PMID: 23583263 Spanish.
-
Aggressive disseminated Rhizomucor pusillus infection in a Ph-like acute lymphoblastic leukemia patient: Early detection by cell-free DNA next-generation sequencing.J Infect Chemother. 2022 Mar;28(3):459-464. doi: 10.1016/j.jiac.2021.12.007. Epub 2021 Dec 23. J Infect Chemother. 2022. PMID: 34955408
-
[Invasive zygomycosis in patients treated for haematological malignancies].Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2597-602. Ned Tijdschr Geneeskd. 2007. PMID: 18161258 Dutch.
-
Leukemia followed by mixed infection with mucormycosis and aspergillosis: A case report and literature review.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Jul 28;48(7):1105-1112. doi: 10.11817/j.issn.1672-7347.2023.230039. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37724414 Free PMC article. Review. Chinese, English.
-
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.Ann Pharmacother. 2016 Sep;50(9):747-57. doi: 10.1177/1060028016655425. Epub 2016 Jun 15. Ann Pharmacother. 2016. PMID: 27307416 Review.
Cited by
-
Hepatosplenic mucormycosis due to Rhizomucor pusillus identified by panfungal PCR/sequencing of ribosomal ITS2 and LSU regions in a patient with acute myelogenous leukemia: A case report.J Assoc Med Microbiol Infect Dis Can. 2023 Mar 1;8(1):105-110. doi: 10.3138/jammi-2022-0020. eCollection 2023 Mar. J Assoc Med Microbiol Infect Dis Can. 2023. PMID: 37008581 Free PMC article.
References
LinkOut - more resources
Full Text Sources